StonvexLoading…
StonvexStonvexStonvexCore line items from CAVA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-28 | Annual 2024 2024-12-29 | Annual 2023 2023-12-31 | Annual 2022 2022-12-25 |
|---|---|---|---|---|
Revenue | $1.18B | $963.71M | $728.70M | $564.12M |
Operating Income | $55.28M | $43.12M | $4.72M | $-59.77M |
Net Income | $63.74M | $130.32M | $13.28M | $-58.99M |
EPS (Diluted) | $0.54 | $1.10 | $0.21 | $-44.41 |
Total Assets | $1.36B | $1.17B | $983.76M | $583.88M |
Total Liabilities | $580.37M | $474.10M | $412.95M | $370.08M |
Cash & Equivalents | $282.92M | $366.12M | $332.43M | $39.13M |
Free Cash Flow OCF − CapEx | $26.14M | $52.90M | $-41.70M | $-98.12M |
Shares Outstanding | 116.13M | 115.09M | 113.71M | 1.41M |